Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : JTWO - J2 Communications - National Lampoon -- Ignore unavailable to you. Want to Upgrade?

To: leigh aulper who wrote (29)	7/16/1999 6:20:00 PM
From: Jim Burnham	Respond to of 54

Or said another less technical way... J2 Communications Adopts Poison Pill With 15% Trigger By John Seward, Staff Reporter LOS ANGELES -(Dow Jones)- J2 Communications, the parent company of the National Lampoon comedy franchise, announced Friday its board has adopted a shareholder rights plan, more commonly known as a poison pill, with a 15% trigger. J2 Communications, which licenses the National Lampoon name to movie makers, said the plan isn't being adopted in response to any specific effort to acquire control of the company. The plan is exercisable if a person or group acquires 15% or more of the company, or, in the case of investors Daniel Laikin and Paul Skjodt, 25%, or in the case of James P. Jimirro, who is chairman, chief executive officer and president, 39%. As of July 14, Jimirro owns nearly 29% of the company's common stock and Laikin and Skjodt, as a group, own nearly 22%. Poison pills are agreements that, when triggered by a hostile bid or a bidder's accumulation of stock, give shareholders the right to buy additional securities at favorable prices, thus making the takeover unpalatably expensive. -John Seward; 201-938-5400